← FDA DRUG APPROVALS

FDA ANDA · ANDA204085

OXYCODONE HYDROCHLORIDE

Sponsor: CHARTWELL MOLECULAR

APPLICATION
ANDA204085
TYPE
ANDA
ORIGINAL APPROVAL
2014-09-10
LATEST ACTION
2020-11-05
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

OXYCODONE HYDROCHLORIDEDiscontinued
OXYCODONE HYDROCHLORIDE 100MG/5ML · SOLUTION · ORAL

Approval history

2020-11-05Labeling · Supplement 6 · standardAP
2020-11-05Labeling · Supplement 9 · standardAP
2018-09-18REMS · Supplement 4AP
2015-09-25Manufacturing (CMC) · Supplement 1 · unknownAP
2014-09-10UNKNOWN · OriginalREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →